- According to estimates from 23 analysts, Guardant Health, Inc. stock's average price target has risen from $153.96 to $156.35, with forecasts ranging from $125 to $200 per share
- Based on the Jul. 2 closing price, the updated target implies approximately 7% potential downside
- Consensus rating remains at “Buy” across 29 covering analysts, with 25 Buys, 2 Holds and 2 Sells
Explore more price target data and ratings for Guardant Health, Inc. on the , and track all previous and future analyst recommendations for Guardant Health, Inc. in the dedicated .
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.